Webinar: Developing A Scalable Upstream Bioreactor Process for Lentiviral Vector Production in Suspension

by Jessica Hogan | September 1, 2021

Art of Gene Therapy main image

Gene therapies hold the promise to change lives. As your path to patients accelerates, how can you assure the robust process design, intensification and scalability that meets your evolving manufacturing needs? And what benefits can a templated process bring to your commercial success?

Learn the answers to these questions and more in this webinar.

 

Related Posts

Strengthening the CDMO-Sponsor Partnership with Improved Data Sharing and Collaboration

Collaboration between biomanufacturers and CDMOs often experiences challenges with data sharing. This presentation highlights the management of heterogenous...

Curious to learn more on PAT, Raman Spectroscopy, and Chemometrics?

Are you curious about Process Analytical Technologies (PAT), Raman spectroscopy, chemometrics and Raman applications in bioprocessing? Watch this...

What to consider for a modular facility with closed processing

The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…

Watch on Demand! Advance Scientific Innovation with M Lab™ Collaboration Centers Panel Discussion

Join us for this panel discussion to discover how a large global network of scientific experts, innovative technologies,...

Breaking perceptions of TFF in gene therapy manufacturing

The tangential flow filtration (TFF) unit operation in viral vector manufacturing is a critical step on the path…

Watch on Demand! 4th Annual Virtual Biotech Startup Symposium

We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups...

Scroll to Top